PT-141 spray 10 mg · 10 mL, 10 ml spray bottle, pump and overcap, Amino Party Peptides label

Sprays

PT-141 spray

PT-141 was the working name for bremelanotide during development. It is a synthetic peptide with seven amino acids arranged in a ring, modeled on alpha-melanocyte-stimulating hormone, and has been described as a derivative of Melanotan II.

10 mg · 10 mLPTY-PT141-SP-10$50.99
Choose a size and add to cart →
Container
10 mL spray bottle, pump and overcap
Storage
2 to 8 °C, protect from light
Per bottle
10 mg PT-141 · 1 mg/mL
Paperwork
Lot certificate (HPLC + mass spec) shown before you pay

What researchers study it for

  • Hypoactive sexual desire disorder in women before menopause
  • Sexual arousal disorder in women
  • Erectile function studies in men
  • How the melanocortin-4 receptor signals in the brain

How it is thought to work

Bremelanotide switches on melanocortin receptors without much selectivity between subtypes; the melanocortin-4 receptor is thought to matter most. Work in animals points to hypothalamic neurons and a rise in dopamine release. Even so, the FDA label says plainly that how the drug produces its clinical effect is not known.

Where the research stands

Approved medicine under the name bremelanotide (Vyleesi). US regulators cleared bremelanotide in 2019 for one specific diagnosis: acquired, generalized hypoactive sexual desire disorder in women who have not reached menopause. Two randomized phase 3 trials supported that decision, and a subsequent re-analysis argued the gain was modest. None of this extends beyond the licensed medicine.

Sources

  1. Kingsberg SA, et al. (2019). Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials. Obstetrics and Gynecology.
  2. Dhillon S, Keam SJ. (2019). Bremelanotide: First Approval. Drugs.
  3. Pfaus JG, et al. (2022). The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women. CNS Spectrums.
  4. Diamond LE, et al. (2006). An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist. The Journal of Sexual Medicine.

For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.

Amino Party Peptides

Your cart

0 items · free shipping over $200.00

Your cart is empty.

Buy 2 of a vial and save 10%, 3 and save 15%. Research sets are 15% off, and shipping is free over $200.00.